Conversely, leukemia and lymphoma cells markedly depend on the activation of HIF-1a signaling during exposure to biguanides, being resistant to biguanide-induced complex I dysfunction mediated by HIF1α-regulated transcriptional rewiring of glucose metabolism [201]. The gene discussed is HIF1A; the disease is lymphoma.